'Mitochondrial Disease: translating biology into new treatments', Cambridge, UK
2 October 2013 - 2 October 2013
United Kingdom
An event entitled 'Mitochondrial Disease: translating biology into new treatments' will be held from 2 to 4 October 2013 in Cambridge, UK.
Mitochondrial diseases result from failures of the mitochondria, specialized compartments present in every cell of the body except red blood cells. Mitochondria are responsible for creating more than 90% of the energy needed by the body to sustain life and support growth. When they fail, less and less energy is generated within the cell. Cell injury and even cell death follow. If this process is repeated throughout the body, whole systems begin to fail and life is severely compromised.
The disease is complex and under diagnosed due to a lack of physician and public awareness. It may appear at anytime - at birth, in the teen years or as an adult. It also has links to other more familiar disorders: autism, Parkinson's, Alzheimer's, Lou Gehrig's disease (ALS), muscular dystrophy.
Over the last two decades, we have seen the emergence of mitochondrial medicine as a distinct clinical discipline. The prospect of a molecular diagnosis for all patients, coupled with advances in understanding pathophysiology and treatments, has moved the field into a new "translational era".
The conference will be an opportunity for researchers to share and exchange on treatments and latest research results that could prevent and treat this disease.For further information, please visit:
http://registration.hinxton.wellcome.ac.uk/display_info.asp?id=349(opens in new window)
Mitochondrial diseases result from failures of the mitochondria, specialized compartments present in every cell of the body except red blood cells. Mitochondria are responsible for creating more than 90% of the energy needed by the body to sustain life and support growth. When they fail, less and less energy is generated within the cell. Cell injury and even cell death follow. If this process is repeated throughout the body, whole systems begin to fail and life is severely compromised.
The disease is complex and under diagnosed due to a lack of physician and public awareness. It may appear at anytime - at birth, in the teen years or as an adult. It also has links to other more familiar disorders: autism, Parkinson's, Alzheimer's, Lou Gehrig's disease (ALS), muscular dystrophy.
Over the last two decades, we have seen the emergence of mitochondrial medicine as a distinct clinical discipline. The prospect of a molecular diagnosis for all patients, coupled with advances in understanding pathophysiology and treatments, has moved the field into a new "translational era".
The conference will be an opportunity for researchers to share and exchange on treatments and latest research results that could prevent and treat this disease.For further information, please visit:
http://registration.hinxton.wellcome.ac.uk/display_info.asp?id=349(opens in new window)